Association of Warfarin Use With CHADS₂ Score in 441 Patients With Nonvalvular Atrial Fibrillation and No Contraindications to Warfarin

By Desai Harit V.   Aronow Wilbert S.   Gandhi Kaushang   Bakerywala Suhalia   Laimuanpuii Judy   Sharma Mala   Peterson Stephen J.  

Preventive Cardiology, Vol. 13, Iss. 4, 2010-0 ,pp. : 172-174

Blackwell Publishing

Access to resources Recommend Favorite

Very low dose bevacizumab for the treatment of epistaxis in patients with hereditary hemorrhagic telangiectasia

By Thompson Andrew B.   Ross Douglas A.   Berard Paul   Figueroa-Bodine Jaszmin   Livada Nancy   Richer Sara L.  

Allergy & Rhinology, Vol. 5, Iss. 2, 2014-07 ,pp. : 91-95

OceanSide Publications, Inc

Access to resources Recommend Favorite

Medication Station: Reducing Anticoagulation-Related Adverse Drug Events: Closely monitoring and managing risks for patients on warfarin

By  

Joint Commission Perspectives on Patient Safety, Vol. 6, Iss. 7, 2006-07 ,pp. : 3-4

Joint Commission Resources

Access to resources Recommend Favorite

Racial background is a determinant factor in the maintenance dosage of Warfarin

By Gan Gin   Teh Alan   Goh Kim   Chong Heng   Pang Kang  

International Journal of Hematology, Vol. 78, Iss. 1, 2003-02 ,pp. : 84-86

Springer Publishing Company

Access to resources Recommend Favorite

Patient understanding of warfarin therapy: A review of education strategies

By Newall Fiona   Monagle Paul   Johnston Linda  

Hematology, Vol. 10, Iss. 6, 2005-12 ,pp. : 437-442

Maney Publishing

Access to resources Recommend Favorite